ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
SG&A Expense Growth TrendStable
Percentile Rank18
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Latest
0.00%
↑ 100% vs avg
Percentile
P18
Within normal range
Average
-14.38%
Historical baseline
PeriodValue
Q4 20250.00%
Q3 20250.00%
Q2 2025-100.00%
Q1 202560.57%
Q4 20240.00%
Q3 2024-100.00%
Q2 20249.66%
Q1 20240.00%
Q4 20230.00%
Q3 20230.00%
Q2 2023-100.00%
Q1 2023-45.53%
Q4 20220.00%
Q3 20220.00%
Q2 2022-100.00%
Q1 20220.00%
Q4 20210.00%
Q3 20210.00%
Q2 2021-100.00%
Q1 20210.00%
Q4 20200.00%
Q3 20200.00%
Q2 2020-100.00%
Q1 20200.00%
Q4 20190.00%
Q3 20190.00%
Q2 20190.00%
Q3 20180.00%
Q1 20180.00%
Q3 20170.00%
Q1 20170.00%
Q1 20160.00%
Q2 20150.00%
Q1 20150.00%
Q3 20130.00%
Q1 20130.00%
Q3 20120.00%
Q1 20120.00%
Q1 20110.00%
Q1 20100.00%